Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 18 (BNIP3P18)

Target: BNIP3P18
Molecular classification: Other (Pseudogene)

Overview

BNIP3P18 is a pseudogene that shares sequence similarity with the protein-coding BCL2 interacting protein 3 (BNIP3) gene, but it does not encode a functional protein. Unlike BNIP3, which is involved in apoptosis and autophagy pathways, BNIP3P18 lacks coding potential and is not considered a drug target or a source of biological function. As a pseudogene, it has no documented role in disease or therapy.

Other names: BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 18BNIP3P18

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 18 (BNIP3P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 18 (BNIP3P18).

Explore the full profile